| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/13/2007 | US7189557 Fermentation for high cell density culture; thrombolytic agents; genetically engineered plasmid carries kanamycin resistant marker |
| 03/13/2007 | US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 03/13/2007 | US7189517 Goodpasture antigen binding protein |
| 03/13/2007 | US7189513 Human papilloma virus immunoreactive peptides |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189413 Drug delivery of proteins from polymeric blends |
| 03/13/2007 | US7189405 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 03/13/2007 | US7189404 Strain selection of pneumococcal surface proteins |
| 03/13/2007 | US7189403 Attenuated flavivirus strains containing a mutated M-ectodomain and their applications |
| 03/13/2007 | US7189402 Live vaccine for human immunodeficiency virus |
| 03/13/2007 | US7189401 Modified viral geomes for use in vectors or vaccines. Replication of DNA or DNA polymerase |
| 03/13/2007 | US7189400 Fusion protein for use in the treatment and prevention of autoimmune and cancer diseases |
| 03/13/2007 | US7189399 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained |
| 03/13/2007 | US7189398 Amino acid sequence substantially homologous to the amino acid sequence of a fragment of a pyrogenic exotoxin, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin |
| 03/13/2007 | US7189397 Screening fir cytotoxic end points; cancerous disease modifying antibodies |
| 03/13/2007 | US7189396 Delivery system using mAb 3E10 and mutants and/or functional fragments thereof |
| 03/13/2007 | US7189395 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 03/13/2007 | US7189394 Method for treating inflammation |
| 03/13/2007 | CA2394609C Conformational and topological protein regulation |
| 03/13/2007 | CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna |
| 03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/13/2007 | CA2160922C Hiv immunogenic complexes |
| 03/13/2007 | CA2101463C Recombinant adenovirus vaccines |
| 03/08/2007 | WO2007028154A2 Encapsulated arsenic drugs |
| 03/08/2007 | WO2007028144A2 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 03/08/2007 | WO2007028041A2 Loading of cells with antigens by electroporation |
| 03/08/2007 | WO2007027805A2 Method for generating anti-variable region monoclonal antibodies |
| 03/08/2007 | WO2007027761A2 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 03/08/2007 | WO2007027748A2 C/clp antagonists and methods of use thereof |
| 03/08/2007 | WO2007027714A2 Engineered anti-il-23 antibodies |
| 03/08/2007 | WO2007027713A2 Trail receptor 2 polypeptides and antibodies |
| 03/08/2007 | WO2007027640A2 Stabilized virus-like particles and epitope display systems |
| 03/08/2007 | WO2007027509A2 Evaluating and treating scleroderma |
| 03/08/2007 | WO2007027321A2 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| 03/08/2007 | WO2007027076A1 Vaccine stabilising formula with live antigens for use in mass vaccination systems |
| 03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
| 03/08/2007 | WO2007026689A1 Antibody produced using ostrich and method for production thereof |
| 03/08/2007 | WO2007026567A1 ANALGESIC AGENT COMPRISING p75NTR INHIBITOR AS ACTIVE INGREDIENT |
| 03/08/2007 | WO2007026249A2 Multiple vaccination including serogroup c meningococcus |
| 03/08/2007 | WO2007026247A1 Vaccines containing corynebacterium diphtheriae pili |
| 03/08/2007 | WO2007026146A1 Treatment using herpes simplex virus |
| 03/08/2007 | WO2007026078A2 T cd4+ epitopes of mage-a antigens restricted to hla-dp4 and the use thereof |
| 03/08/2007 | WO2007025781A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | WO2007025441A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 03/08/2007 | WO2007025431A1 Recombinant newcastle disease lasota attenuated vaccine strain expressing vp2 gene of infectious bursal disease virus |
| 03/08/2007 | WO2007025420A1 Low virulent strain of recombinant newcastle disease lasota vaccine expressing ha protein of avian influenza-h5 virus |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
| 03/08/2007 | WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/08/2007 | WO2007025365A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | WO2007011216A3 Bifunctional protein anchors |
| 03/08/2007 | WO2007011216A2 Bifunctional protein anchors |
| 03/08/2007 | WO2006135447A9 Viral chimera compositions and methods |
| 03/08/2007 | WO2006131936A3 Hepatitis c virus vaccine |
| 03/08/2007 | WO2006124712A3 A method for improving the immunogenicity of plasmodium antigens |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | WO2006113522A3 Methods of detecting hepatitis c virus |
| 03/08/2007 | WO2006111925A3 Inhibition of tumorigenesis by inhibition of a6b4 integrin |
| 03/08/2007 | WO2006110760A3 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | WO2006105021A3 Gitr binding molecules and uses therefor |
| 03/08/2007 | WO2006098621A3 Cross-beta structure on microbial organisms |
| 03/08/2007 | WO2006091412A3 Adamts-7 as a biomarker for cancers of epithelial origin |
| 03/08/2007 | WO2006085933A3 Immunogenic domains of sars coronavirus |
| 03/08/2007 | WO2006076691A3 Irta-2 antibodies and their uses |
| 03/08/2007 | WO2006071983A3 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 03/08/2007 | WO2006038101A3 Novel cancer associated antibodies and antigens and their use in cancer diagnosis |
| 03/08/2007 | WO2006020935A3 Stabilizing formulations |
| 03/08/2007 | WO2005123966A3 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 03/08/2007 | WO2005094415A3 Recombinant vectors and methods for inducing an immune response |
| 03/08/2007 | WO2005039393A3 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | US20070055054 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070055053 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/08/2007 | US20070055052 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070055051 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 03/08/2007 | US20070055050 Methods and reagents for diagnosis and treatment of diabetes |
| 03/08/2007 | US20070054858 Method of treating hepatocellular carcinoma |
| 03/08/2007 | US20070054856 Compositions and methods of using angiopoietin-like 4 protein |
| 03/08/2007 | US20070054848 Composition and method for nerve regeneration |
| 03/08/2007 | US20070054378 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 03/08/2007 | US20070054377 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070054376 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/08/2007 | US20070054375 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 03/08/2007 | US20070054374 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054362 Recombinant production of mixtures of antibodies |
| 03/08/2007 | US20070054361 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053938 Virulence of streptococci |
| 03/08/2007 | US20070053937 Antigen of hybrid M protein and carrier for group a streptococcal vaccine |
| 03/08/2007 | US20070053936 Expression vector comprising nucleotide sequences coding microorganismal polypeptide for use in generating agents for prevention and treatment of infection |
| 03/08/2007 | US20070053935 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection |
| 03/08/2007 | US20070053934 Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same |
| 03/08/2007 | US20070053933 IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME |
| 03/08/2007 | US20070053928 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 03/08/2007 | US20070053927 Chlamydia pneumoniae polynucleotides and uses thereof |
| 03/08/2007 | US20070053926 Antigenic neisserial peptides |
| 03/08/2007 | US20070053925 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 03/08/2007 | US20070053924 Conserved and specific streptococcal genomes |
| 03/08/2007 | US20070053923 Dna vaccine composition with enhanced immunogenicity |